Global /United States /Healthcare /Medical Devices /BRKR
chevron_leftBack
Bruker Corp. logo

Bruker Corp.

BRKR
NASDAQ: BRKR Delayed
34.29USD -5.4%
As of 14 June 2026, Bruker Corp. has a market cap of $5.22B USD, ranking #3655 globally and #1092 in the United States. It ranks #285 in the Healthcare sector, and #66 in the Medical Devices industry.
Global Rank
3655
Country Rank
1092
Sector Rank
285
Industry Rank
66
Key Stats
Market Cap
$5.22BUSD
Enterprise Value
$6.94BUSD
Revenue (TTM)
$3.44BUSD
EBITDA (TTM)
$499.9MUSD
Net Income (TTM)
-$22.5MUSD
EBITDA Margin
15%
Profit Margin
-0.3%
Forward PE
16.2
PS Ratio
1.5
PB Ratio
2.2
EV/EBITDA
13.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Frank Laukien open_in_new
Employees
11,085
Founded
1960
IPO
04 Aug 2000
Website
bruker.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-5.4% -15% 1.1% -27% -12% -14%

News

Loading...

BRKR Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
BRKR
Bruker Corp
ISIN: US1167941087
Shares Out.:
152.226M1 Shares Float: 111.122M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
34.29 USD
Borsa Italiana
MIC: XMIL
1BRKR
Bruker Corp
ISIN: US1167941087
TV:
SA:
YF:
GF:
BA:
MS:
30.83 EUR
Frankfurt Stock Exchange
MIC: XFRA
BKD
Bruker Corp
ISIN: US1167941087
TV:
SA:
YF:
GF:
BA:
BKD
MS:
30.91 EUR
Show all 4 markets
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Bruker Corp.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
3K%
25.8
$160.73B
3K%
56.7
$159.07B
3K%
25.6
DHR
$126.55B
2K%
34.7
SYK
$120.69B
2K%
38.3
$84.93B
2K%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
2K%
22.2
$97.46B
84.32B EUR
2K%
36.7
7741
$61.41B
9.83T JPY
1K%
40.0
$45.47B
39.34B EUR
771%
18.7
ALC
$36.38B
28.99B CHF
597%
37.9
$30.06B
203.66B CNY
476%
26.0
chevron_leftBack